These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 22825057)
1. TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin. Yang N; Morrison CD; Liu P; Miecznikowski J; Bshara W; Han S; Zhu Q; Omilian AR; Li X; Zhang J Cell Cycle; 2012 Aug; 11(15):2922-30. PubMed ID: 22825057 [TBL] [Abstract][Full Text] [Related]
2. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway. Zhang J; Ji JY; Yu M; Overholtzer M; Smolen GA; Wang R; Brugge JS; Dyson NJ; Haber DA Nat Cell Biol; 2009 Dec; 11(12):1444-50. PubMed ID: 19935651 [TBL] [Abstract][Full Text] [Related]
4. Reversible interconversion and maintenance of mammary epithelial cell characteristics by the ligand-regulated EGFR system. Fukuda S; Nishida-Fukuda H; Nanba D; Nakashiro K; Nakayama H; Kubota H; Higashiyama S Sci Rep; 2016 Feb; 6():20209. PubMed ID: 26831618 [TBL] [Abstract][Full Text] [Related]
5. The ADAM17-amphiregulin-EGFR axis in mammary development and cancer. Sternlicht MD; Sunnarborg SW J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):181-94. PubMed ID: 18470483 [TBL] [Abstract][Full Text] [Related]
6. Autocrine-derived epidermal growth factor receptor ligands contribute to recruitment of tumor-associated macrophage and growth of basal breast cancer cells in vivo. Nickerson NK; Mill CP; Wu HJ; Riese DJ; Foley J Oncol Res; 2013; 20(7):303-17. PubMed ID: 23879171 [TBL] [Abstract][Full Text] [Related]
7. Knock-down of amphiregulin inhibits cellular invasion in inflammatory breast cancer. Baillo A; Giroux C; Ethier SP J Cell Physiol; 2011 Oct; 226(10):2691-701. PubMed ID: 21302279 [TBL] [Abstract][Full Text] [Related]
8. Non-canonical HIF-2α function drives autonomous breast cancer cell growth via an AREG-EGFR/ErbB4 autocrine loop. Stiehl DP; Bordoli MR; Abreu-Rodríguez I; Wollenick K; Schraml P; Gradin K; Poellinger L; Kristiansen G; Wenger RH Oncogene; 2012 May; 31(18):2283-97. PubMed ID: 21927022 [TBL] [Abstract][Full Text] [Related]
9. Amphiregulin mediates estrogen, progesterone, and EGFR signaling in the normal rat mammary gland and in hormone-dependent rat mammary cancers. Kariagina A; Xie J; Leipprandt JR; Haslam SZ Horm Cancer; 2010 Oct; 1(5):229-44. PubMed ID: 21258428 [TBL] [Abstract][Full Text] [Related]
10. OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ. Zhang Z; Du J; Wang S; Shao L; Jin K; Li F; Wei B; Ding W; Fu P; van Dam H; Wang A; Jin J; Ding C; Yang B; Zheng M; Feng XH; Guan KL; Zhang L Mol Cell; 2019 Jan; 73(1):7-21.e7. PubMed ID: 30472188 [TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 determines estrogen signaling in the mammary gland in vivo. Casimiro MC; Wang C; Li Z; Di Sante G; Willmart NE; Addya S; Chen L; Liu Y; Lisanti MP; Pestell RG Mol Endocrinol; 2013 Sep; 27(9):1415-28. PubMed ID: 23864650 [TBL] [Abstract][Full Text] [Related]
12. Metalloproteinase-mediated, context-dependent function of amphiregulin and HB-EGF in human keratinocytes and skin. Stoll SW; Johnson JL; Bhasin A; Johnston A; Gudjonsson JE; Rittié L; Elder JT J Invest Dermatol; 2010 Jan; 130(1):295-304. PubMed ID: 19609315 [TBL] [Abstract][Full Text] [Related]
13. Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells. Willmarth NE; Ethier SP J Biol Chem; 2006 Dec; 281(49):37728-37. PubMed ID: 17035230 [TBL] [Abstract][Full Text] [Related]
14. Histamine may induce airway remodeling through release of epidermal growth factor receptor ligands from bronchial epithelial cells. Hirota N; Risse PA; Novali M; McGovern T; Al-Alwan L; McCuaig S; Proud D; Hayden P; Hamid Q; Martin JG FASEB J; 2012 Apr; 26(4):1704-16. PubMed ID: 22247333 [TBL] [Abstract][Full Text] [Related]
15. Amphiregulin carboxy-terminal domain is required for autocrine keratinocyte growth. Stoll SW; Johnson JL; Li Y; Rittié L; Elder JT J Invest Dermatol; 2010 Aug; 130(8):2031-40. PubMed ID: 20428186 [TBL] [Abstract][Full Text] [Related]
16. Validation of HB-EGF and amphiregulin as targets for human cancer therapy. Yotsumoto F; Yagi H; Suzuki SO; Oki E; Tsujioka H; Hachisuga T; Sonoda K; Kawarabayashi T; Mekada E; Miyamoto S Biochem Biophys Res Commun; 2008 Jan; 365(3):555-61. PubMed ID: 18023415 [TBL] [Abstract][Full Text] [Related]
17. Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat pad. Nickerson NK; Mohammad KS; Gilmore JL; Crismore E; Bruzzaniti A; Guise TA; Foley J PLoS One; 2012; 7(1):e30255. PubMed ID: 22276166 [TBL] [Abstract][Full Text] [Related]
18. The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer. Li Z; Wang Y; Zhu Y; Yuan C; Wang D; Zhang W; Qi B; Qiu J; Song X; Ye J; Wu H; Jiang H; Liu L; Zhang Y; Song LN; Yang J; Cheng J Mol Oncol; 2015 Jun; 9(6):1091-105. PubMed ID: 25704916 [TBL] [Abstract][Full Text] [Related]
19. The role of amphiregulin in exemestane-resistant breast cancer cells: evidence of an autocrine loop. Wang X; Masri S; Phung S; Chen S Cancer Res; 2008 Apr; 68(7):2259-65. PubMed ID: 18381432 [TBL] [Abstract][Full Text] [Related]
20. Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Sternlicht MD; Sunnarborg SW; Kouros-Mehr H; Yu Y; Lee DC; Werb Z Development; 2005 Sep; 132(17):3923-33. PubMed ID: 16079154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]